Postoperative Radiotherapy in Rectosigmoid Cancer Dukes' B and C: Interim Report from a Randomized Multicentre Study
Overview
Authors
Affiliations
The design, and complications seen during the first 2 years, of a randomized trial of postoperative radiotherapy for rectosigmoid cancer Dukes' B and C are presented and discussed. It is concluded that the present complication rate-below 10% in 221 patients-permits continuation of the intake, which is planned to include 550 patients, to demonstrate a possible increase in crude 5-year survival by 15% (60-75% in Dukes' B and 25-40% in Dukes' C), on the basis of a 0·01 significance level and a probability that the experiment will be successful of 0·90.
Adjuvant therapy in colorectal cancer.
House A J R Soc Med. 1984; 77(6):445-50.
PMID: 6737402 PMC: 1439811. DOI: 10.1177/014107688407700601.
Kronborg O, Hage E, Fenger C, Deichgraeber E Int J Colorectal Dis. 1986; 1(2):99-103.
PMID: 3611942 DOI: 10.1007/BF01648415.
Bentzen S, Balslev I, Pedersen M, Teglbjaerg P, Bone J, Jacobsen N Br J Cancer. 1988; 58(2):195-201.
PMID: 3166910 PMC: 2246758. DOI: 10.1038/bjc.1988.192.
Bentzen S, Balslev I, Pedersen M, Teglbjaerg P, Bone J, Jacobsen N Br J Cancer. 1992; 65(1):102-7.
PMID: 1733432 PMC: 1977364. DOI: 10.1038/bjc.1992.19.